CompletedNCT04991974
Patient navigation and buprenorphine to link people with opioid care
About this title
Read the official source —Medication studyAges 18+United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- Baltimore and 1 more locationSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateStarted: September 17, 2021
- Recruitment status
- Completed
- Enrollment listed in the registry
- 373
- Sponsor
- Friends Research Institute, Inc.
- Sponsor type
- Research institute
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Phase 2, Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT04991974
- Official title
Show the full official title
Opioid Use Disorder Treatment Linkage at Strategic Touchpoints Using Buprenorphine
Get this study by email
Recruitment & locations
CompletedBaltimore
Questions about this study
Who is behind this study?
The study sponsor is Friends Research Institute, Inc., a research institute.
Did this study involve medication?
Yes. The study involved medication, including Buprenorphine.
Who was this study for?
Listed age limits: from 18 years.
